1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions

Optowire for measuring fractional flow reserve

Medtech innovation briefing [MIB199] Published date: December 2019

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Specialist commentator comments
  • Specialist commentators
  • Development of this briefing
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download
    • Save
    • Save as PDF
    • Save as ePub
    • Save as eBook

Advice

  • Next

Regulatory information

Regulatory information

Opsens Optowire is CE marked as a class III medical device. It received its CE mark in 2014.


  • Next